Panagiotis Repousis
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Aggressive T-Cell Large Granular Lymphocyte Leukemia With the Unusual Double-Negative CD4-/CD8-/TCRαβ+ Phenotype; Report of Two Cases and Review of the Literature.
Journal: International journal of laboratory hematology
Published: March 25, 2025
Floating Carotid Thrombus in a Patient With Essential Thrombocytemia due to Calreticulin Mutation.
Journal: Stroke
Published: March 13, 2023
Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World "POWERFUL" Study.
Journal: Journal of clinical medicine
Published: March 13, 2021
The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.
Journal: British journal of haematology
Published: June 06, 2020
Integrating multi-disciplinary discussion in clinical practice.
Journal: Advances in respiratory medicine
Published: October 24, 2019
Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 17, 2019
Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group.
Journal: Journal of geriatric oncology
Published: March 28, 2019
A revised international prognostic score system for Waldenström's macroglobulinemia.
Journal: Leukemia
Published: September 25, 2018
The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5-azacytidine: Results from the Hellenic 5-azacytidine registry.
Journal: Cancer medicine
Published: September 08, 2018
The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.
Journal: Hematological oncology
Published: August 03, 2018
Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis.
Journal: Hematological oncology
Published: January 30, 2018
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.
Journal: Hematological oncology
Published: September 13, 2016
Last Updated: 09/26/2026